Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $19.12, but opened at $21.97. Ascentage Pharma Group International shares last traded at $21.80, with a volume of 9,780 shares.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a research note on Thursday, March 27th. They issued an “overweight” rating on the stock.
Check Out Our Latest Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- Where Do I Find 52-Week Highs and Lows?
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Take-Two Interactive: A Defensive Play Set to Explode
- Dividend Capture Strategy: What You Need to Know
- 4 Stocks With +3% Yields and 50+ Years of Dividend Increases
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
